International Stem Cell Corporation (ISCO)

USD 0.07

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 7.78 Million 8.18 Million 7.17 Million 7.12 Million 9.47 Million 11.08 Million
Cost of Revenue 3.18 Million 3.26 Million 2.93 Million 2.78 Million 3.93 Million 4.06 Million
Gross Profit 4.6 Million 4.91 Million 4.24 Million 4.34 Million 5.53 Million 7.02 Million
Operating Expenses 5.27 Million 5.09 Million 6.16 Million 7.16 Million 11.26 Million 10.49 Million
Selling, General and Administrative Expenses 4.76 Million 4.6 Million 5.46 Million 6.17 Million 9.88 Million 8.09 Million
Research and Development Expenses 511 Thousand 492 Thousand 695 Thousand 988 Thousand 1.38 Million 2.39 Million
Other Expenses - -13 Thousand 13 Thousand - 2000.00 23 Thousand
Cost and Expenses 8.45 Million 8.36 Million 9.09 Million 9.94 Million 15.2 Million 14.56 Million
Operating Income -663 Thousand -196 Thousand -1.92 Million -2.81 Million -5.72 Million -3.47 Million
Interest Expense 139 Thousand 135 Thousand 128 Thousand 113 Thousand 77 Thousand 48 Thousand
Income Tax Expense - 135 Thousand 141 Thousand 113 Thousand 79 Thousand 1.39 Million
Earnings before Tax -131 Thousand -331 Thousand -899 Thousand -2.72 Million -4.26 Million -2.13 Million
Net Income -131 Thousand -466 Thousand -1.04 Million -2.83 Million -4.34 Million -2.13 Million
Earnings Per Share Basic -0.02 -0.06 -0.13 -0.38 -0.58 -0.33
Earnings Per Share Diluted -0.02 -0.06 -0.13 -0.38 -0.58 -0.33
Weighted Average Shares Outstanding 8 Million 8 Million 7.83 Million 7.53 Million 7.51 Million 6.38 Million
Weighted Average Shares Outstanding (Diluted) 8 Million 8 Million 7.83 Million 7.53 Million 7.51 Million 6.38 Million
Gross Margin 0.59 0.60 0.59 0.61 0.58 0.63
EBIT Margin 0.03 0.00 -0.23 -0.36 -0.57 -0.28
Profit Margin -0.02 -0.06 -0.14 -0.40 -0.46 -0.19
EBITDA 202 Thousand 22 Thousand -220 Thousand -2.35 Million -3.9 Million -1.77 Million
Earnings Before Tax Margin -0.09 -0.02 -0.27 -0.40 -0.60 -0.31

Income Statement Charts